This invention relates to the field of clinical
virus detection, and more particularly to a
protein dot blot detection kit, detection method, and application for varicella-zoster
virus (VZV). The kit includes: a
solid-phase carrier membrane for binding and immobilizing proteins in the sample; a blocking agent for blocking non-specific binding sites on the
solid-phase carrier membrane; a first
antibody that specifically recognizes the VZV
antigen; an
enzyme-labeled second
antibody that binds to the first
antibody; and a
chromogenic solution for generating a detection
signal. This kit is based on
protein dot blot technology, detecting proteins with high specificity and a low false-positive rate. The experimental cycle is short, taking only 2-3 hours from sample pretreatment to
signal detection, much faster than
virus culture (requiring 4-7 days) and PCR detection (although fast, prone to false positives or false negatives), providing rapid evidence for
clinical treatment, and is particularly suitable for the diagnosis of acute herpes zoster.